E-LIB Suche - Ergebnisse für: De Seze, J.

1

P.011 Efficacy and safety of ravulizumab in adults with AQP..:

Pittock, SJ ; Barnett, M ; Bennett, JL...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques. 51 (2024) s1 - p. S17-S17 , 2024

Link: https://doi.org/10.1017/..

2

Clinical applications of deep learning in neuroinflammatory..:

Demuth, S. ; Paris, J. ; Faddeenkov, I...
Revue Neurologique. , 2024

Link: https://doi.org/10.1016/..

3

P-53 Efficacy and safety of ravulizumab in adults with anti..:

Pittock, S. ; Barnett, M. ; Bennett, J.L....
Clinical Neurophysiology. 148 (2023) - p. e32 , 2023

Link: https://doi.org/10.1016/..

4

A decade of fingolimod in multiple sclerosis: Insights from..:

Gauer, L. ; Bigaut, K. ; Berger, É....
Revue Neurologique. 179 (2023) 6 - p. 576-584 , 2023

Link: https://doi.org/10.1016/..

5

Impact of methodological choices in comparative effectivene..:

Lefort, M. ; Sharmin, S. ; Andersen, J. B....
BMC Medical Research Methodology. 22 (2022) 1 - p. , 2022

Link: https://doi.org/10.1186/..

6

Reverse Takotsubo cardiomyopathy as a complication of MOG-a..:

Bogdan, T. ; El Ghannudi, S. ; Demuth, S....
Revue Neurologique. 178 (2022) 9 - p. 981-983 , 2022

Link: https://doi.org/10.1016/..

7

La méningite rhumatoïde, une complication indépendante de l..:

Jemili, C. ; Gottenberg, J.E. ; Moreau, P....
Revue du Rhumatisme. 89 (2022) - p. A211-A212 , 2022

Link: https://doi.org/10.1016/..

8

Identification and measurement of cervical spinal cord atro..:

Lersy, F. ; Noblet, V. ; Willaume, T....
Revue Neurologique. 177 (2021) 1-2 - p. 85-92 , 2021

Link: https://doi.org/10.1016/..

9

Impact of disease-modifying treatments on humoral response ..:

Bigaut, K. ; Kremer, L. ; Fleury, M....
Revue Neurologique. 177 (2021) 10 - p. 1237-1240 , 2021

Link: https://doi.org/10.1016/..

10

Infections and multiple sclerosis: Recommendations from the..:

Papeix, C. ; Donze, C. ; Lebrun-Frénay, C....
Revue Neurologique. 177 (2021) 8 - p. 980-994 , 2021

Link: https://doi.org/10.1016/..

11

Treatment of MOG antibody associated disorders: results of ..:

Whittam, D. H. ; Karthikeayan, V. ; Gibbons, E....
Journal of Neurology. 267 (2020) 12 - p. 3565-3577 , 2020

Link: https://doi.org/10.1007/..

12

Do disease-modifying drugs (DMD) have a positive impact on ..:

de Seze, J. ; Bigaut, K.
Revue Neurologique. 176 (2020) 6 - p. 497-499 , 2020

Link: https://doi.org/10.1016/..

13

Atypical myelitis in patients with multiple sclerosis: Char..:

Bigaut, K ; Lambert, C ; Kremer, L...
Multiple Sclerosis Journal. 27 (2020) 2 - p. 232-238 , 2020

Link: https://doi.org/10.1177/..

14

Urinary tract infections and multiple sclerosis: Recommenda..:

Donzé, C. ; Papeix, C. ; Lebrun-Frenay, C....
Revue Neurologique. 176 (2020) 10 - p. 804-822 , 2020

Link: https://doi.org/10.1016/..

15

Covid-19, the pandemic war: Implication for neurologists:

de Seze, J. ; Lebrun-Frenay, C.
Revue Neurologique. 176 (2020) 4 - p. 223-224 , 2020

Link: https://doi.org/10.1016/..